Stock Price
1.31
Daily Change
0.09 7.38%
Monthly
14.91%
Yearly
-11.49%
Q2 Forecast
1.19

Actinium Pharmaceuticals reported $1.53M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.58B 316M Mar/2026
Actinium Pharmaceuticals USD 1.53M 1.09M Sep/2025
Amgen USD 1.58B 354M Mar/2026
Bioline Rx USD 831K 622K Sep/2025
Capricor Therapeutics USD 1.92M 446.47K Dec/2025
Pfizer USD 2.92B 1.16B Mar/2026